Literature DB >> 9306037

Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.

S W Park1, S H Ihm, H J Yoo, J Y Park, K U Lee.   

Abstract

We student basal, glucose- and glucagon-induced insulin secretion in non-insulin diabetes mellitus (NIDDM) patients in relation to body mass index (BMI) and fasting serum glucose (FBS) level. A total of 46 NIDDM patients and 22 control subjects with varying degrees of BMI and FBS were given 100 g of oral glucose and 1 mg of intravenous glucagon on separate days. C-peptide response to glucose, but not basal serum C-peptide and C-peptide response to glucagon, was significantly lower in NIDDM than in controls (P < 0.001). FBS was inversely correlated with C-peptide response to glucose in NIDDM patients (r = -0.67, P < 0.001), but not with basal C-peptide level and C-peptide response to glucagon. On the other hand, BMI was positively correlated with basal serum C-peptide level both in NIDDM (r = 0.60, P < 0.001) and in control subjects (r = 0.74, P < 0.001). In 15 poorly controlled NIDDM patients, the tests were repeated after insulin treatment for 10-14 days. C-peptide response to glucose significantly increase, but not to a level in control subjects, after glycemic control. Basal serum C-peptide level and the C-peptide response to glucagon decreased after glycemic control to significantly lower levels than those in the baseline and those in control subjects. These results suggest that beta cell secretory reserve is reduced in moderate to severe NIDDM patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9306037     DOI: 10.1016/s0168-8227(97)00069-7

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  2 in total

1.  Utility of indices using C-peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes.

Authors:  Shogo Funakoshi; Shimpei Fujimoto; Akihiro Hamasaki; Hideya Fujiwara; Yoshihito Fujita; Kaori Ikeda; Shiho Takahara; Kazuaki Nagashima; Masaya Hosokawa; Yutaka Seino; Nobuya Inagaki
Journal:  J Diabetes Investig       Date:  2011-08-02       Impact factor: 4.232

2.  Analysis of SNPs of MC4R, GNB3 and FTO gene polymorphism in obese Saudi subjects.

Authors:  Said Salama Moselhy; Yasmeen A Alhetari; Archana Iyer; Etimad A Huwait; Maryam A Al-Ghamdi; Shareefa Al-Ghamdi; Khadijah Saeed Balamash; Ashraf A Basuni; Mohamed N Alama; Taha A Kumosani; Soonham Sami Yaghmoor
Journal:  Afr Health Sci       Date:  2017-12       Impact factor: 0.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.